首页|脑小血管病患者外周血GPER30、NPAS4、FKBP5表达与认知功能障碍的相关性研究

脑小血管病患者外周血GPER30、NPAS4、FKBP5表达与认知功能障碍的相关性研究

扫码查看
目的 探讨脑小血管病(CSVD)患者外周血G蛋白耦联雌激素受体30(GPER30)、神经元PAS结构域蛋白4(NPAS4)、FK506结合蛋白5(FKBP5)表达与认知功能障碍(CD)的相关性。方法 前瞻性选取2022年1月至2023年12月郑州大学第二附属医院收治的227例CSVD患者,根据有无CD分为障碍组(n=66)与无障碍组(n=161)。比较两组患者的一般资料及外周血GPER30、NPAS4、FKBP5 mRNA表达水平,Logistic回归分析CSVD患者CD的影响因素,比较不同程度CD患者外周血GPER30、NPAS4、FKBP5 mRNA表达水平,采用Pearson法分析外周血GPER30、NPAS4、FKBP5 mRNA表达与蒙特利尔认知评估量表(MoCA)评分的相关性。结果 障碍组患者的年龄、病程分别为(72。49±5。68)岁、(2。69±0。78)年,明显高(长)于无障碍组的(67。51±7。04)岁、(2。31±0。62)年,差异均有统计学意义(P<0。05);障碍组患者的外周血GPER30 mRNA表达水平为1。02±0。17,明显低于无障碍组的1。66±0。31,NPAS4 mRNA、FKBP5 mRNA表达水平分别为2。79±0。60、3。88±1。12,明显高于无障碍组的1。55±0。51、2。10±0。59,差异均有统计学意义(P<0。05);Logistic回归分析结果显示,年龄、病程、GPER30 mRNA、NPAS4 mRNA及FKBP5 mRNA均为CSVD患者CD的独立影响因素(P<0。05)。轻度组患者的外周血GPER30 mRNA表达水平为1。27±0。25,明显高于中重度组的0。70±0。12,NPAS4 mRNA、FKBP5 mRNA表达水平分别为2。31±0。58、3。19±1。07,明显低于中重度组的3。40±0。72、4。76±1。39,差异均有统计学意义(P<0。05);Pearson法分析结果显示,外周血GPER30 mRNA表达与CSVD患者MoCA评分呈正相关(r=0。704,P<0。05),NPAS4 mRNA、FKBP5 mRNA与MoCA评分呈负相关(r=-0。572、-0。542,P<0。05)。结论 外周血GPER30、NPAS4、FKBP5是CSVD患者CD的独立相关因素,各指标表达水平与CD病情严重程度均具有一定相关性,可为临床判断CD、评估CD病情严重程度提供参考,以指导后续临床工作。
Correlation between expression of GPER30,NPAS4,FKBP5 in peripheral blood and cognitive dysfunction in patients with small cerebral vascular disease
Objective To investigate the correlation between the expression of G protein-coupled estrogen re-ceptor 30(GPER30),neuronal PAS domain protein 4(NPAS4),FK506-binding protein 5(FKBP5)in peripheral blood and cognitive dysfunction(CD)in patients with small cerebral vascular disease(CSVD).Methods A prospective study was conducted on 227 patients with CSVD admitted to the Second Affiliated Hospital of Zhengzhou University from Jan-uary 2022 to December 2023.They were divided into a barrier group(n=66)and a non-barrier group(n=161)based on the presence or absence of CD.The general information and peripheral blood GPER30,NPAS4,FKBP5 mRNA expres-sion levels of the two groups of patients were compared.Logistic regression analysis was used to analyze the influencing factors of CSVD patients'CD.The peripheral blood GPER30,NPAS4,FKBP5 mRNA expression levels of patients with different degrees of CI were compared.Pearson correlation analysis was used to analyze the correlation between peripheral blood GPER30,NPAS4,FKBP5 mRNA expression and Montreal Cognitive Assessment(MoCA)scores.Results The age and disease duration of patients in the barrier group were(72.49±5.68)years and(2.69±0.78)years,respectively,which were significantly higher than(67.51±7.04)years and(2.31±0.62)years in the non-barrier group(P<0.05).The ex-pression level of GPER30 mRNA in peripheral blood of patients with obstacles was 1.02±0.17,which was significantly lower than 1.66±0.31 of patients without obstacles,and the expression levels of NPAS4 mRNA and FKBP5 mRNA were 2.79±0.60 and 3.88±1.12,respectively,which were significantly higher than 1.55±0.51 and 2.10±0.59 of patients without obstacles,with statistically significant differences(P<0.05).The results of logistic regression analysis showed that age,disease duration,GPER30 mRNA,NPAS4 mRNA,and FKBP5 mRNA were all independent factors affecting CD in pa-tients with CSVD(P<0.05).The expression of GPER30 mRNA in the peripheral blood of patients in the mild group was 1.27±0.25,which was significantly higher than 0.70±0.12 in the moderate and severe groups,and the expression levels of NPAS4 mRNA and FKBP5 mRNA were 2.31±0.58,3.19±1.07,which were significantly lower than 3.40±0.72,4.76±1.39 in the moderate and severe groups,with statistically significant differences(P<0.05).Pearson correlation analysis showed that the expression of GPER30 mRNA in peripheral blood was positively correlated with the MoCA score in CS-VD patients(r=0.704,P<0.05),while NPAS4 mRNA and FKBP5 mRNA were negatively correlated with MoCA score(r=-0.572,-0.542,P<0.05).Conclusion GPER30,NPAS4,and FKBP5 in peripheral blood are independent correlation factors of CD in CSVD patients,and the expression level of each indicator is correlated with the severity of CD to some extent,which can provide reference for clinical judgment and evaluation of the severity of CD and can guide the fol-low-up clinical work.

Small cerebral vascular diseaseG protein-coupled estrogen receptor 30(GPER30)Neuronal PAS domain protein 4(NPAS4)FK506 binding protein 5(FKBP5)Cognitive dysfunctionCorrelation

连浩军、侯立维、邢媛媛

展开 >

郑州大学第二附属医院神经内科,河南 郑州 450000

脑小血管病 G蛋白耦联雌激素受体30 神经元PAS结构域蛋白4 FK506结合蛋白5 认知功能障碍 相关性

2025

海南医学
海南省医学会

海南医学

影响因子:1.158
ISSN:1003-6350
年,卷(期):2025.36(1)